Android app on Google Play

BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform

January 15, 2014 7:02 AM EST Send to a Friend
Get Alerts REGN Hot Sheet
Price: $359.92 +0.28%

Rating Summary:
    16 Buy, 11 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 25 | New: 14
Trade REGN Now!
Join SI Premium – FREE
BMO Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform to Market Perform with a price target of $331.00 (unchanged)

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $268.68 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

BMO Capital

Add Your Comment